Skip to content

Clinical trials

Phase 3 Crohn Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Germany Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20044
20051
20068
20071
20082
20093
20102
20118
20121
20141
20153
20166
20178
201810
20193
20203
20213
20221
20231
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated17
Recruiting10
Active, not recruiting7
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie9
Janssen Research & Development, LLC9
Celgene7
UCB Pharma6
Eli Lilly and Company4
GlaxoSmithKline4
Takeda4
Abbott3
Dr. Falk Pharma GmbH3
Janssen-Cilag Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease80
Inflammatory Bowel Diseases11
Colitis, Ulcerative6
Colitis3
Arthritis, Psoriatic2
Anemia1
Anemia, Iron-Deficiency1
Arthritis, Juvenile1
Deficiency Diseases1
Fistula1

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.